Asia-Pacific Journal of Clinical Oncology
© Wiley Publishing Asia Pty Ltd
Edited By: Stephen ACKLAND, Australia
Impact Factor: 1.542
ISI Journal Citation Reports © Ranking: 2014: 174/211 (Oncology)
Online ISSN: 1743-7563
Recently Published Issues
Current Issue:September 2015
Volume 11, Issue 3
Volume 11, Issue Supplement S3
Special Issue: Abstracts of The Medical Oncology G...
Volume 11, Issue Supplement S2
Special Issue: ANZUP Annual Scientific Meeting, Re...
Volume 11, Issue 2
Volume 11, Issue Supplement S1
Special Issue: Evolving Treatment Paradigms in Lun...
Top Cited Papers in 2013 (Read FREE)
href="http://onlinelibrary.wiley.com/enhanced/doi/10.1111/j.1743-7563.2012.01548.x/?isReportingDone=true">Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue
Fermín Mar-Aguilar, Claudia M Luna-Aguirre, J. Claudio Moreno-Rocha, et al.
MG132, a proteasome inhibitor, induces apoptosis in tumor cells
Na Guo, Zhilan Peng
Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy
Daliu Min, Feng Lin, Zan Shen, et al.
Endoscopic self-expandable metallic stent placement in malignant pyloric or duodenal obstruction: Does chemotherapy affect stent patency?
Byung Hyo Cha, Sang Hyub Lee, Jang Eun Kim, et al.
Interventions to improve patient participation in the treatment process for culturally and linguistically diverse people with cancer: A systematic review
Aisha Harun, James D. Harrison and Jane M. Young
Clinical Oncology Virtual Issue (for ASCO 2014) - Read NOW!
Top Read Clinical Oncology Papers 2014 (Read FREE)
Options for diagnosis and treatment of urachal carcinoma
Jianwen Zhang and Jingbo Wu
Review of high-dose intravenous vitamin C as an anticancer agent
Michelle K Wilson, Bruce C Baguley, Clare Wall, Michael B Jameson and Michael P Findlay
Special Issue: The Use of Vemurafenib in Australian Patients with Unresectable or Metastatic Melanoma Containing the V600 BRAF Gene Mutation
Michael P Brown and Georgina V Long
Controversies in the management of gastrointestinal stromal tumors
Desmond Yip, John Zalcberg, Stephen Ackland, Andrew P Barbour, et al.
Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?
Peter J Smith, Alexandra Clavarino, Jeremy Long and Kathryn J Steadman